Report #2860226

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: FL
Recovered: Unknown
Vaccinated: Oct 25, 2022
Onset: —
Days to onset: —
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	W001494	—
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	W001494	—

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

The patient did not receive the third dose yet.; No additional AEs; This spontaneous report was received from a Pharmacist and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 25-Oct-2022, the patient was vaccinated with the 1st dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #W001494, expiration date: 15-Sep-2024), 1 dosage form total for prophylaxis. On 04-Dec-2022, the patient was vaccinated with the 2nd dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #W001494, expiration date: 15-Sep-2024), 1 dosage form, total for prophylaxis. The patient did not receive the third dose yet (Inappropriate schedule of vaccine administered). No additional adverse event (no adverse event).